Christophe Bourdon

Christophe Bourdon

Director/Board Member at SWEDISH ORPHAN BIOVITRUM AB
56 year
Health Technology
Consumer Services
Health Services

Profile

Christophe Bourdon is Chief Executive Officer at LEO Pharma A since 2022.
Mr. Bourdon is Independent Director at Swedish Orphan Biovitrum AB since 2023.
Formerly, Mr. Bourdon was Chief Executive Officer at Strategic Partners A from 2021 to 2022.
Mr. Bourdon was Senior Vice President & General Manager-US Oncology at Amgen, Inc. from 2020 to 2021.
Mr. Bourdon was Senior VP-Europe, Middle East, Africa & Canada at Alexion Pharmaceuticals, Inc. from 2015 to 2017.
Mr. Bourdon earned an MBA from the International Institute for Management Development and completed undergraduate studies at Institut Supérieur de Gestion.

Christophe Bourdon active positions

CompaniesPositionStart
SWEDISH ORPHAN BIOVITRUM AB Director/Board Member 31/12/2022
Chief Executive Officer 31/12/2021

Former positions of Christophe Bourdon

CompaniesPositionEnd
STRATEGIC PARTNERS A/S Chief Executive Officer 31/03/2022
AMGEN INC. Corporate Officer/Principal 28/02/2021
ALEXION PHARMACEUTICALS, INC. Corporate Officer/Principal 31/10/2017
See the detail of Christophe Bourdon's experience

Training of Christophe Bourdon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Services

Consumer Services

Health Technology

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Christophe Bourdon